Spirapril is a potent angiotensin-converting enzyme inhibitor primarily prescribed for the management of hypertension. Administered as a prodrug, it undergoes biotransformation in the body into its active… Read more
Spirapril is a potent angiotensin-converting enzyme inhibitor primarily prescribed for the management of hypertension. Administered as a prodrug, it undergoes biotransformation in the body into its active metabolite, spiraprilat, to exert its therapeutic antihypertensive effects. This category provides a comprehensive selection of high-quality analytical reference standards, including the active pharmaceutical ingredient, its hydrochloride monohydrate salt form, and system suitability mixtures. These materials are essential for pharmaceutical laboratories engaged in impurity profiling, method validation, and rigorous quality control testing. By utilizing these precise reference standards, researchers can accurately identify, quantify, and monitor degradation products and metabolic pathways throughout the drug development and manufacturing lifecycle. Stable isotope labelled compounds and specific impurity standards are also available to support complex analytical studies, ensuring that drug safety and efficacy profiles meet established regulatory guidelines for this class of cardiovascular medications.